 |
|
|
| |
TREATMENT WITH SOF/VEL/VOX IN HIV-HCV COINFECTED PATIENTS
PREVIOUSLY EXPOSED TO DAAs
|
| |
| |
CROI 2022 Feb 11-16
Luz Martin Carbonero1, Angela Gil-Martin2, Teresa Aldámiz-Echevarría3, Vicente Estrada4, Carlos Barros5, Rebeca Font6, Pablo Ryan7, Carmen Quereda8, Beatriz Alvarez9, Rafael Mican1, Juan Berenguer3, JorgeVergas4, Maria Luisa Montes1, Juan Carlos Lopez Bernaldo3,
for Madrid-CoRe Study Group. 1La Paz University Hospital, Madrid; 2 Subdireccion General de Farmacia, Madrid; 3HospitalGeneral Universitario Gregorio Marañón, Madrid; 4Hospital Universitario Clínico San Carlos, Madrid; 5Hospital Universitario de Móstoles, Madrid;
6Hospital Universitario 12 de Octubre, Madrid; 7Hospital Universitario Infanta Leonor, Madrid; 8Hospital Ramón y Cajal, Madrid; 9FundacionJimenez Diaz, Madrid. Spain.
|
| |
|
|
|
|
|
